Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Proponents often emphasize the opportunity for significant therapeutic gains, particularly in diseases where conventional therapies have proven inadequate. However, this is to consider the significant financial investment associated with CPI stem cell the